| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
346,617 | 413,024 | 406,399 | 379,821 | 236,441 |
| Cost of Revenue
|
-304,200 | -367,466 | -289,455 | -220,051 | -139,186 |
|
Gross Profit
|
42,417 | 45,558 | 116,944 | 159,770 | 97,255 |
| Selling, General and Administrative Expenses
|
-99,389 | -97,722 | -43,223 | -44,384 | -27,132 |
|
Research and Development Expenses
|
-37,876 | -52,089 | -46,608 | -35,333 | -26,355 |
| Other Income/Expense, Operating
|
2,252 | 3,432 | 1,264 | 1,331 | 1,341 |
|
Operating Income/Expenses
|
-135,013 | -146,379 | -88,567 | -78,386 | -52,146 |
|
Total Operating Profit/Loss
|
-92,596 | -100,821 | 28,377 | 81,384 | 45,109 |
| Total Net Finance Income/Expense
|
-194 | 168 | 331 | 513 | 306 |
| Net Investment Income
|
2,391 | -78 | 2,243 | 781 | 7,884 |
|
Other Income/Expense, Non-Operating
|
328 | 48 | -392 | 835 | 1,780 |
|
Non-Operating Income/Expenses, Total
|
2,525 | 138 | 2,182 | 2,129 | 9,970 |
|
Pretax Income
|
-90,071 | -100,683 | 30,559 | 83,513 | 55,079 |
|
Provision for Income Tax
|
-148 | -96 | 0 | -21 | 0 |
|
Net Income from Continuing Operations
|
-90,219 | -100,779 | 30,559 | 83,492 | 55,079 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-90,219 | -100,779 | 30,559 | 83,492 | 55,079 |
|
Non-Controlling/Minority Interests
|
7,436 | 6,432 | -10,288 | -12,995 | -2,316 |
|
Net Income after Non-Controlling/Minority Interests
|
-82,783 | -94,347 | 20,271 | 70,497 | 52,763 |
|
Net Income Available to Common Stockholders
|
-82,783 | -94,347 | 20,271 | 70,497 | 52,763 |
|
Diluted Net Income Available to Common Stockholders
|
-82,783 | -94,347 | 20,271 | 70,497 | 52,763 |
| Basic EPS
|
13.50 | -31.50 | 18.00 | 27.52 | 20.60 |
| Diluted EPS
|
13.50 | -31.50 | 18.00 | 27.52 | 20.60 |
|
Basic Weighted Average Shares Outstanding
|
3,045.7690 | 2,781.4270 | 1,036.3780 | 2,561.6460 | 2,561.6460 |
|
Diluted Weighted Average Shares Outstanding
|
3,045.7690 | 2,781.4270 | 1,145.8670 | 2,561.6460 | 2,561.6460 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-89,877 | -100,851 | 30,228 | 83,000 | 54,773 |
|
EBITDA
|
-53,704 | -62,083 | 59,788 | 96,067 | 66,181 |
|
Normalized EBITDA
|
-10,222 | -20,036 | 59,795 | 96,106 | 66,123 |
|
Normalized Income
|
-46,737 | -58,732 | 30,566 | 83,530.9883 | 55,021 |
|
Total Unusual Items
|
43,482 | 42,047 | 7 | 39 | -58 |
12/31/2022 - 12/6/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade